Bliley Requests FDA Plan To Link Bulk Drug Imports With GMP Compliance
Executive Summary
Rep. Bliley (R-Va.) is asking FDA to formulate a plan to provide import inspectors with access to good manufacturing practices compliance information to determine whether bulk drugs should be detained.
You may also be interested in...
APP Accounts For 1% Of Premier Drug Spend: Response To Times Article
American Pharmaceutical Partners accounts for 1% of drugs purchased by Premier, the company said
APP Accounts For 1% Of Premier Drug Spend: Response To Times Article
American Pharmaceutical Partners accounts for 1% of drugs purchased by Premier, the company said
Bulk Drug Import Quality Reports May Be Required From U.S. Firms
Pharmaceutical manufacturers may be required to notify FDA when they receive bulk drugs of poor quality, FDA Associate Commissioner for Regulatory Affairs Dennis Baker told a House subcommittee hearing June 8.